{"id":18494,"date":"2021-09-27T07:45:35","date_gmt":"2021-09-26T23:45:35","guid":{"rendered":"https:\/\/www.whatchina.cn\/?p=18494"},"modified":"2021-09-27T07:46:29","modified_gmt":"2021-09-26T23:46:29","slug":"drug-rd-comprehensive-strength-ranking","status":"publish","type":"post","link":"https:\/\/www.whatchina.cn\/drug-rd-comprehensive-strength-ranking.html","title":{"rendered":"2021 China&#8217;s Drug R&#038;D Comprehensive Strength Ranking"},"content":{"rendered":"<div class=\"37c28470d9d6d3cb9ff74e663adb766a\" data-index=\"2\" style=\"float: none; margin:0px 0 0px 0; text-align:center;\">\n<script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-3594734025006597\"\r\n     crossorigin=\"anonymous\"><\/script>\n<\/div>\n<p>At the 6th China Pharmaceutical R&amp;D and Innovation Summit, Yaozhi.com released the &#8220;2021 China Pharmaceutical R&amp;D Comprehensive Strength Ranking&#8221;. The list comprehensively ranks the drug acceptance and approval status of each company in 2020, the R&amp;D investment funds of pharmaceutical companies, the completion of clinical trials and the patent layout, and finally selects 100 companies including Jiangsu Hengrui Pharmaceutical and Zhengda Tianqing Pharmaceutical Group.<br \/>\n<img decoding=\"async\" class=\"alignnone size-full wp-image-18497\" src=\"https:\/\/www.whatchina.cn\/wp-content\/uploads\/2021\/09\/2021-Chinas-Drug-RD-Comprehensive-Strength-Ranking.jpg\" alt=\"2021 China's Drug R&amp;D Comprehensive Strength Ranking\" width=\"640\" height=\"400\" srcset=\"https:\/\/www.whatchina.cn\/wp-content\/uploads\/2021\/09\/2021-Chinas-Drug-RD-Comprehensive-Strength-Ranking.jpg 640w, https:\/\/www.whatchina.cn\/wp-content\/uploads\/2021\/09\/2021-Chinas-Drug-RD-Comprehensive-Strength-Ranking-300x188.jpg 300w\" sizes=\"(max-width: 640px) 100vw, 640px\" \/><br \/>\n<strong>2021 China&#8217;s Drug R&amp;D Comprehensive Strength Ranking<\/strong><br \/>\n[table id=30 \/]\nInterpretation of the domestic pharmaceutical research and development rankings in 2021<br \/>\nAccording to the 2021 R&amp;D ranking of Chinese pharmaceutical companies, the top 100 companies on the list have a total of 559 new drug acceptance numbers in 2020, accounting for 48.44% of the 1,154 new drug acceptance numbers in the country, and 416 category 1 new drugs accounting for 46.83% of the country. This directly explains The enthusiasm of the top 100 companies in the research and development of new drugs.<br \/>\nAccording to corporate financial reports and corporate public information, the top 100 pharmaceutical companies on the R&amp;D investment ranking list have invested a total of 65 billion yuan in research and development. Among them, 16 companies have invested more than 1 billion yuan in research and development. BeiGene invested the most, reaching 8.327 billion yuan, and the research and development expenditures of the top 100 companies are increasing year by year.<br \/>\nCompared with previous years&#8217; list, a total of 66 companies have risen in 2021, of which 26 are newcomers, and major pharmaceutical companies have fierce competition in drug research and development.<\/p>\n<div class=\"37c28470d9d6d3cb9ff74e663adb766a\" data-index=\"2\" style=\"float: none; margin:0px 0 0px 0; text-align:center;\">\n<script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-3594734025006597\"\r\n     crossorigin=\"anonymous\"><\/script>\n<\/div>\n\n<div style=\"font-size: 0px; height: 0px; line-height: 0px; margin: 0; padding: 0; clear: both;\"><\/div>","protected":false},"excerpt":{"rendered":"<p>At the 6th China Pharmaceutical R&amp;D and Innovation Summit, Yaozhi.com released the &#8220;2021 China Pharmaceutical&#8230;<\/p>\n","protected":false},"author":1,"featured_media":18497,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0,"footnotes":""},"categories":[84],"tags":[1986,1988,1987],"class_list":["post-18494","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","tag-china-medicine","tag-china-medicine-innovation","tag-china-medicine-rd"],"_links":{"self":[{"href":"https:\/\/www.whatchina.cn\/wp-json\/wp\/v2\/posts\/18494","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.whatchina.cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.whatchina.cn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.whatchina.cn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.whatchina.cn\/wp-json\/wp\/v2\/comments?post=18494"}],"version-history":[{"count":0,"href":"https:\/\/www.whatchina.cn\/wp-json\/wp\/v2\/posts\/18494\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.whatchina.cn\/wp-json\/wp\/v2\/media\/18497"}],"wp:attachment":[{"href":"https:\/\/www.whatchina.cn\/wp-json\/wp\/v2\/media?parent=18494"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.whatchina.cn\/wp-json\/wp\/v2\/categories?post=18494"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.whatchina.cn\/wp-json\/wp\/v2\/tags?post=18494"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}